Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/1/23 → 07/24/25 |
Funding
- Boehringer Ingelheim Pharmaceutical: $24,577.50
A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over at least 52 weeks in patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
- Desai, Alpa (PI)
- Patel, Jignesh (CoPI)
Project: Research